Fig. 1
From: Integrin αvβ6-targeted MR molecular imaging of breast cancer in a xenograft mouse model
Characterization of the nanoprobe. a The schematic synthesis route and structure model of integrin αvβ6-targeted MR nanoprobe (cFK-9-USPIO); b The size and histogram analysis of cFK-9-USPIO and USPIO under transmission electron microscope (TEM); c T2-Weighted MRI images (3.0 T, Discovery MR 750, GE Medical System, Milwaukee, WI, USA) of increasing cFK-9-USPIO concentrations (mM); D T2 relaxation rate (1/T2, S− 1) versus cFK-9-USPIO concentration at 3.0 T